Ha, G., K. Kwong, B. Tanaka, Y. Nishimura, and C. Chong. “Are Patients With HHV-8 Associated Castleman Disease Successfully Treated With Rituximab at Risk of Subsequently Developing HHV-8 Negative (idiopathic) Castleman Disease? IMCD After HHV-8-Associated MCD”. European Journal of Case Reports in Internal Medicine, vol. 10, no. 7, June 2023, doi:10.12890/2023_003904.